Mucosal expression of cyclooxygenase isoforms 1 and 2 is increased with worsening damage to the gastric mucosa

被引:26
作者
Bhandari, P
Bateman, AC
Mehta, RL
Patel, P
机构
[1] Southampton Univ Hosp, Dept Gastroenterol, Southampton, Hants, England
[2] Southampton Univ Hosp, Dept Cellular Pathol, Southampton, Hants, England
[3] Southampton Univ Hosp, Dept Med Stat, Res & Dev Support Unit, Southampton, Hants, England
关键词
cyclooxygenase; gastric ulcer; gastritis; Helicobacter pylori; immunohistochemistry;
D O I
10.1111/j.1365-2559.2005.02053.x
中图分类号
Q2 [细胞生物学];
学科分类号
071009 [细胞生物学]; 090102 [作物遗传育种];
摘要
Aims: To test the hypothesis that both COX-1 and COX-2 expression in human gastric mucosa is up-regulated in the presence of inflammation as seen in patients with gastritis and gastric ulcers. Methods and results: We performed immunohistochemistry using COX-1 and COX-2 monoclonal antibodies on gastric biopsies from 59 patients with normal mucosa, gastritis and gastric ulcers. Expression of COX-1 and COX-2 was quantified using an intensity proportion scoring system. Expression of COX-1 was primarily seen in the lamina propria mononuclear cells with some expression in deep gastric glands in the ulcer group. Expression of COX-2 was primarily seen in the deep gastric glands with focal expression in the lamina propria mononuclear cells. We found a stepwise increase in the expression of both COX-1 and COX-2 as mucosal damage progressed from normal to gastritis to gastric ulcer. Conclusions: We conclude that both COX-1 and COX-2 expression in the gastric mucosa are increased in the setting of gastritis and gastric ulceration. Although this increased expression may be due, at least in part, to an increase in inflammatory cell numbers, this study raises the possibility that both COX-1 and COX-2 are inducible, contrary to the traditionally held view of only COX-2 being inducible.
引用
收藏
页码:280 / 286
页数:7
相关论文
共 18 条
[1]
CEHUNG LY, 1980, AM J PHYSIOL, V238, pG514
[2]
CHAN CC, 1995, J PHARMACOL EXP THER, V274, P1531
[3]
Increased expression and cellular localization of inducible nitric oxide synthase and cyclooxygenase 2 in Helicobacter pylori gastritis [J].
Fu, SD ;
Ramanujam, KS ;
Wong, A ;
Fantry, GT ;
Drachenberg, CB ;
James, SP ;
Meltzer, SJ ;
Wilson, KT .
GASTROENTEROLOGY, 1999, 116 (06) :1319-1329
[4]
KARGMAN SL, 1995, CANCER RES, V55, P2556
[5]
Rofecoxib inhibits cyclooxygenase 2 expression and activity and reduces cell proliferation in Barrett's esophagus [J].
Kaur, BS ;
Khamnehei, N ;
Iravani, M ;
Namburu, SS ;
Lin, O ;
Triadafilopoulos, G .
GASTROENTEROLOGY, 2002, 123 (01) :60-67
[6]
KINSEL LB, 1989, CANCER RES, V49, P1052
[7]
LEE SH, 1992, J BIOL CHEM, V267, P25934
[8]
ROLE OF SURFACE-ACTIVE PHOSPHOLIPIDS IN GASTRIC CYTOPROTECTION [J].
LICHTENBERGER, LM ;
GRAZIANI, LA ;
DIAL, EJ ;
BUTLER, BD ;
HILLS, BA .
SCIENCE, 1983, 219 (4590) :1327-1329
[9]
McCarthy CJ, 1999, AM J GASTROENTEROL, V94, P1218, DOI 10.1111/j.1572-0241.1999.01070.x
[10]
Induction of cyclooxygenase 2 in gastric mucosal lesions and its inhibition by the specific antagonist delays healing in mice [J].
Mizuno, H ;
Sakamoto, C ;
Matsuda, K ;
Wada, K ;
Uchida, T ;
Noguchi, H ;
Akamatsu, T ;
Kasuga, M .
GASTROENTEROLOGY, 1997, 112 (02) :387-397